Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1

Journal of Cellular Biochemistry

Volumn 115, Issue 6, 2014, Pages 1033-1042

  Cui, Jianguo ^a   Cheng, Ying ^a   Zhang, Pei ^a   Sun, Mingjuan ^a   Gao, Fu ^a   Liu, Cong ^a   Cai, Jianming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

BMI 1; IN VIVO TUMOR THERAPY; miR 200C; RADIATION CARCINOGENESIS; RADIATION INDUCED THYMIC LYMPHOMA (RITL)

Indexed keywords

BMI1 PROTEIN; MICRORNA 200C; 3' UNTRANSLATED REGION; BMI1 PROTEIN, MOUSE; MICRORNA; MIRN200 MICRORNA, MOUSE; ONCOPROTEIN; RNA PRECURSOR;

3' UNTRANSLATED REGION; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; LUCIFERASE ASSAY; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIATION INDUCED NEOPLASM; RADIATION INDUCED THYMIC LYMPHOMA; THYMUS LYMPHOMA; UPREGULATION; 3T3 CELL LINE; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPHOMA; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASMS, RADIATION-INDUCED; NIH 3T3 CELLS; POLYCOMB REPRESSIVE COMPLEX 1; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS;

EID: 84907421890     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24754     Document Type: Article

References (64)

1. Alajez NM, Shi W, Hui AB, Yue S, Ng R, Lo KW, Bastianutto C, O'Sullivan B, Gullane P, Liu FF,. 2009. Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy. Cell Death Differ 16: 1469-1479.
2. Allegra E, Caltabiano R, Amorosi A, Vasquez E, Garozzo A, Puzzo L,. 2013. Expression of BMI1 and p16 in laryngeal squamous cell carcinoma. Head Neck 35: 847-851.
3. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A,. 2010. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 70: 6609-6618.
4. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J,. 2009. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743.
5. Biehs B, Hu JK, Strauli NB, Sangiorgi E, Jung H, Heber RP, Ho S, Goodwin AF, Dasen JS, Capecchi MR, Klein OD,. 2013. BMI1 represses Ink4a/Arf and Hox genes to regulate stem cells in the rodent incisor. Nat Cell Biol 15: 846-852.
6. Boniver J, Decleve A, Finn OJ, Honsik C, Lieberman M, Kaplan HS,. 1980. Detection of infectious centers in C57BL/Ka lymphoid cell populations infected in vitro by the radiation leukemia virus. Cancer Res 40: 544-549.
7. Boominathan L,. 2010. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS ONE 5: e10615.
8. Calao M, Sekyere EO, Cui HJ, Cheung BB, Thomas WD, Keating J, Chen JB, Raif A, Jankowski K, Davies NP, Bekkum MV, Chen B, Tan O, Ellis T, Norris MD, Haber M, Kim ES, Shohet JM, Trahair TN, Liu T, Wainwright BJ, Ding HF, Marshall GM,. 2012. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene 32 (31): 3616-3626.
9. Caramel J, Lacroix M, Le Cam L, Sardet C,. 2011. E4F1 connects the Bmi1-ARF-p53 pathway to epidermal stem cell-dependent skin homeostasis. Cell Cycle 10: 866-867.
10. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC,. 2011. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317-323.
11. Chatoo W, Abdouh M, Duparc RH, Bernier G,. 2010. Bmi1 distinguishes immature retinal progenitor/stem cells from the main progenitor cell population and is required for normal retinal development. Stem Cells 28: 1412-1423.
12. Chen J, Tian W, Cai H, He H, Deng Y,. 2012. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29: 2527-2534.
13. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH,. 2013. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 34 (4): 803-811.
14. Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK,. 2012. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther 11: 2556-2565.
15. Corvo R, Foppiano F, Orsatti M, Bisi F, Ghiso G, Martinelli R, Valanzola L, Vitale V,. 1997. [The application of the multileaf collimator in radiotherapy: The dosimetric problems and the technical implications for its clinical use]. Radiol Med 94: 512-519.
16. Cui J, Yang Y, Cheng Y, Gao F, Liu C, Zhou C, Li B, Cai J,. 2013. Protective effects of carboxyfullerene in irradiated cells and BALB/c mice. Free Radic Res 47: 301-308.
17. D'Amato NC, Howe EN, Richer JK,. 2012. MicroRNA regulation of epithelial plasticity in cancer. Cancer Lett 341 (1): 46-55.
18. Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, Chen T, Luo Y,. 2012. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 205: 113-123.
19. Daya-Grosjean L, Dumaz N, Sarasin A,. 1995. The specificity of p53 mutation spectra in sunlight induced human cancers. J Photochem Photobiol B 28: 115-124.
20. Dell'aversana C, Altucci L,. 2012. miRNA-mediated deregulation in leukemia. Front Genet 3: 252.
21. Fan C, He L, Kapoor A, Gillis A, Rybak AP, Cutz JC, Tang D,. 2008. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression. Biochim Biophys Acta 1782: 642-648.
22. Fang L, Pu YY, Hu XC, Sun LJ, Luo HM, Pan SK, Gu JZ, Cao XR, Su CQ,. 2010. Antiangiogenesis gene armed tumor-targeting adenovirus yields multiple antitumor activities in human HCC xenografts in nude mice. Hepatol Res 40: 216-228.
23. Feng B, Wang R, Chen LB,. 2012. Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother 66: 397-402.
24. Finn OJ, Boniver J, Kaplan HS,. 1979. Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomas. Proc Natl Acad Sci U S A 76: 4033-4037.
25. Fu Z, Huang D, Cai J, Chen Q, Han L, Li B, Wang F, Gao J,. 2006. Expression changes of ERK1/2, STAT3 and SHP-2 in bone marrow cells from gamma-ray induced leukemia mice. J Radiat Res (Tokyo) 47: 121-130.
26. Gargiulo G, Cesaroni M, Serresi M, de Vries N, Hulsman D, Bruggeman SW, Lancini C, van Lohuizen M,. 2013. In vivo RNAi screen for BMI1 targets identifies TGF-beta/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis. Cancer Cell 23: 660-676.
27. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
28. Hao J, Zhang S, Zhou Y, Hu X, Shao C,. 2011a. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 585: 207-213.
29. Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C,. 2011b. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406 (4): 552-557.
30. Herranz M, Martin-Caballero J, Fraga MF, Ruiz-Cabello J, Flores JM, Desco M, Marquez V, Esteller M,. 2006. The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood 107: 1174-1177.
31. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhuang SM, Zheng L, Liang A, Tao W, Cao X,. 2011. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
32. Jing YY, Han ZP, Sun K, Zhang SS, Hou J, Liu Y, Li R, Gao L, Zhao X, Zhao QD, Wu MC, Wei LX,. 2012. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med 10: 98.
33. John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB II, Falduto MT, Magnuson SR, Coleman CN,. 2012. Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res 178: 105-117.
34. Kaplan HS, Brown MB, Paull J,. 1953. Influence of postirradiation thymectomy and of thymic implants on lymphoid tumor incidence in C57BL mice. Cancer Res 13 (9): 677-680.
35. Kaplan HS,. 1960. Experimental alteration of host response to an occult tumor virus: Induction of thymic lymphosarcomas in x-irradiated mice. Natl Cancer Inst Monogr 4: 141-150.
36. Kaplan HS,. 1964. The role of radiation on experimental leukemogenesis. Natl Cancer Inst Monogr 14: 207-220.
37. Kavanagh J, Redmond K, Schettino G, Prise K,. 2013. DSB repair: A radiation perspective. Antioxid Redox Signal.
38. Kopp F, Oak PS, Wagner E, Roidl A,. 2012. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS ONE 7: 50469.
39. Leone V, D'Angelo D, Rubio I, de Freitas PM, Federico A, Colamaio M, Pallante P, Medeiros-Neto G, Fusco A,. 2011. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab 96: E1388-E1398.
40. Lessard J, Schumacher A, Thorsteinsdottir U, van Lohuizen M, Magnuson T, Sauvageau G,. 1999. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev 13: 2691-2703.
41. Li HC, Lu SX,. 1994. [Mutation of p53 gene in human cancers of the esophagus and gastric cardia]. Zhonghua Zhong Liu Za Zhi 16: 172-176.
42. Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X,. 2011. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 286: 36677-36685.
43. Lin J, Liu C, Gao F, Mitchel RE, Zhao L, Yang Y, Lei J, Cai J,. 2013. miR-200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem 114: 606-615.
44. Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin J, Zhao L, Cai J,. 2011a. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21. Leukemia 25: 1516-1519.
45. Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S, Mitchel RE, Sun D, Ni J, Zhao L, Gao F, Cai J,. 2011b. MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci 7: 347-363.
46. Liu C, Lin J, Zhao L, Yang Y, Gao F, Li B, Cui J, Cai J,. 2011c. Gamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosis. Int J Biol Sci 7: 168-179.
47. Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao L, Zhao F, Cao F, Lin J, Yang Y, Ni J, Jia J, Wu W, Zhou L, Cui J, Zhang W, Li B, Cai J,. 2011d. MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury. Int J Biol Sci 7: 221-233.
48. Schenck M, Kliner SJ, Achilles M, Schenck C, Berkovic K, Ruebben H, Stuschke M,. 2010. [Pudendal block or combined spinal-epidural anaesthesia in high-dose-rate brachytherapy for prostate carcinoma?]. Aktuelle Urol 41: 43-51.
49. Schickel R, Park SM, Murmann AE, Peter ME,. 2010. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38: 908-915.
50. Schlechte HH, Schnorr D, Loning T, Rudolph BD, Pohrt UM, Loening SA,. 1997. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers-investigation by temperature gradient gel electrophoresis (TGGE). J Urol 157: 1049-1053.
51. Schubert J, Brabletz T,. 2011. p53 Spreads out further: Suppression of EMT and stemness by activating miR-200c expression. Cell Res 21: 705-707.
52. Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D, Foo J, Subramanian S, Steer CJ,. 2012. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol 9 (10): 1275-1287.
53. Smith LL, Yeung J, Zeisig BB, Popov N, Huijbers I, Barnes J, Wilson AJ, Taskesen E, Delwel R, Gil J, Van Lohuizen M, So CW,. 2011. Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell 8: 649-662.
54. Su C, Na M, Chen J, Wang X, Liu Y, Wang W, Zhang Q, Li L, Long J, Liu X, Wu M, Fan X, Qian Q,. 2008. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy. Mol Cancer Res 6: 568-575.
55. Tian W, Dong X, Liu X, Wang G, Dong Z, Shen W, Zheng G, Lu J, Chen J, Wang Y, Wu Z, Wu X,. 2012. High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays. PLoS ONE 7: e29551.
56. Tirabosco R, De Maglio G, Skrap M, Falconieri G, Pizzolitto S,. 2008. Expression of the Polycomb-Group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases. Pathol Res Pract 204: 625-631.
57. van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ,. 2007. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID. Radiother Oncol 82: 201-207.
58. Wang Y, Lee CG,. 2009. MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 13: 12-23.
59. Wang X, Su C, Cao H, Li K, Chen J, Jiang L, Zhang Q, Wu X, Jia X, Liu Y, Wang W, Liu X, Wu M, Qian Q,. 2008. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers. Mol Cancer Ther 7: 1598-1603.
60. Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y,. 2008. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Cancer Res 68: 3854-3862.
61. Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y,. 2009. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin Cancer Res 15: 4612-4621.
62. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T,. 2009. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495.
63. Wong CF, Tellam RL,. 2008. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283: 9836-9843.
64. Xie X, Piao L, Bullock BN, Smith A, Su T, Zhang M, Teknos TN, Arora PS, Pan Q,. 2013. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene. Epub ahead of print.